Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas

Eleonora Duregon, Luca Bertero, Alessandra Pittaro, Riccardo Soffietti, Roberta Rudà, Morena Trevisan, Mauro Papotti, Laura Ventura, Rebecca Senetta, Paola Cassoni

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Despite several molecular signatures for "lower grade diffuse gliomas" (LGG) have been identified, WHO grade still remains a cornerstone of treatment guidelines. Mitotic count bears a crucial role in its definition, although limited by the poor reproducibility of standard Hematoxylin & Eosin (H&E) evaluation. Phospho-histone-H3 (PHH3) and Ki-67 have been proposed as alternative assays of cellular proliferation. Therefore in the present series of 141 LGG, the molecular characterization (namely IDH status, 1p/19q co-deletion and MGMT promoter methylation) was integrated with the tumor "proliferative trait" (conventional H&E or PHH3-guided mitotic count and Ki-67 index) in term of prognosis definition. Exclusively high PHH3 and Ki-67 values were predictor of poor prognosis (log rank test, P = 0.0281 for PHH3 and P = 0.032 for Ki-67), unlike standard mitotic count. Based on Cox proportional hazard regression analyses, among all clinical (age), pathological (PHH3 and Ki-67) and molecular variables (IDH, 1p/19q codeletion and MGMT methylation) with a prognostic relevance at univariate survival analysis, only IDH expression (P = 0.001) and Ki-67 proliferation index (P = 0.027) proved to be independent prognostic factors. In addition, stratifying by IDH expression status, high Ki-67 retained its prognostic relevance uniquely in the IDH negative patient (P = 0.029) doubling their risk of death (hazard ratio = 2.27). Overall, PHH3 immunostaining is the sole reliable method with a prognostic value to highlight mitotic figures in LGG. Ki-67 proliferation index exceeds PHH3 mitotic count as a predictor of patient's prognosis, and should be integrated with molecular markers in a comprehensive grading system for LGG.

Original languageEnglish
Pages (from-to)21190-21198
Number of pages9
JournalOncotarget
Volume7
Issue number16
DOIs
Publication statusPublished - Apr 19 2016

Fingerprint

Mitotic Index
Glioma
Histones
Methylation
Hematoxylin
Eosine Yellowish-(YS)
Survival Analysis
Regression Analysis
Cell Proliferation
Guidelines

Keywords

  • Ki-67 index
  • Lower grade gliomas
  • Pathology Section
  • Phospho-histone H3
  • Prognosis

ASJC Scopus subject areas

  • Oncology

Cite this

Duregon, E., Bertero, L., Pittaro, A., Soffietti, R., Rudà, R., Trevisan, M., ... Cassoni, P. (2016). Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas. Oncotarget, 7(16), 21190-21198. https://doi.org/10.18632/oncotarget.8498

Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas. / Duregon, Eleonora; Bertero, Luca; Pittaro, Alessandra; Soffietti, Riccardo; Rudà, Roberta; Trevisan, Morena; Papotti, Mauro; Ventura, Laura; Senetta, Rebecca; Cassoni, Paola.

In: Oncotarget, Vol. 7, No. 16, 19.04.2016, p. 21190-21198.

Research output: Contribution to journalArticle

Duregon, E, Bertero, L, Pittaro, A, Soffietti, R, Rudà, R, Trevisan, M, Papotti, M, Ventura, L, Senetta, R & Cassoni, P 2016, 'Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas', Oncotarget, vol. 7, no. 16, pp. 21190-21198. https://doi.org/10.18632/oncotarget.8498
Duregon, Eleonora ; Bertero, Luca ; Pittaro, Alessandra ; Soffietti, Riccardo ; Rudà, Roberta ; Trevisan, Morena ; Papotti, Mauro ; Ventura, Laura ; Senetta, Rebecca ; Cassoni, Paola. / Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas. In: Oncotarget. 2016 ; Vol. 7, No. 16. pp. 21190-21198.
@article{8162285cd619478d9dbd41372dfa8aad,
title = "Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas",
abstract = "Despite several molecular signatures for {"}lower grade diffuse gliomas{"} (LGG) have been identified, WHO grade still remains a cornerstone of treatment guidelines. Mitotic count bears a crucial role in its definition, although limited by the poor reproducibility of standard Hematoxylin & Eosin (H&E) evaluation. Phospho-histone-H3 (PHH3) and Ki-67 have been proposed as alternative assays of cellular proliferation. Therefore in the present series of 141 LGG, the molecular characterization (namely IDH status, 1p/19q co-deletion and MGMT promoter methylation) was integrated with the tumor {"}proliferative trait{"} (conventional H&E or PHH3-guided mitotic count and Ki-67 index) in term of prognosis definition. Exclusively high PHH3 and Ki-67 values were predictor of poor prognosis (log rank test, P = 0.0281 for PHH3 and P = 0.032 for Ki-67), unlike standard mitotic count. Based on Cox proportional hazard regression analyses, among all clinical (age), pathological (PHH3 and Ki-67) and molecular variables (IDH, 1p/19q codeletion and MGMT methylation) with a prognostic relevance at univariate survival analysis, only IDH expression (P = 0.001) and Ki-67 proliferation index (P = 0.027) proved to be independent prognostic factors. In addition, stratifying by IDH expression status, high Ki-67 retained its prognostic relevance uniquely in the IDH negative patient (P = 0.029) doubling their risk of death (hazard ratio = 2.27). Overall, PHH3 immunostaining is the sole reliable method with a prognostic value to highlight mitotic figures in LGG. Ki-67 proliferation index exceeds PHH3 mitotic count as a predictor of patient's prognosis, and should be integrated with molecular markers in a comprehensive grading system for LGG.",
keywords = "Ki-67 index, Lower grade gliomas, Pathology Section, Phospho-histone H3, Prognosis",
author = "Eleonora Duregon and Luca Bertero and Alessandra Pittaro and Riccardo Soffietti and Roberta Rud{\`a} and Morena Trevisan and Mauro Papotti and Laura Ventura and Rebecca Senetta and Paola Cassoni",
year = "2016",
month = "4",
day = "19",
doi = "10.18632/oncotarget.8498",
language = "English",
volume = "7",
pages = "21190--21198",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "16",

}

TY - JOUR

T1 - Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas

AU - Duregon, Eleonora

AU - Bertero, Luca

AU - Pittaro, Alessandra

AU - Soffietti, Riccardo

AU - Rudà, Roberta

AU - Trevisan, Morena

AU - Papotti, Mauro

AU - Ventura, Laura

AU - Senetta, Rebecca

AU - Cassoni, Paola

PY - 2016/4/19

Y1 - 2016/4/19

N2 - Despite several molecular signatures for "lower grade diffuse gliomas" (LGG) have been identified, WHO grade still remains a cornerstone of treatment guidelines. Mitotic count bears a crucial role in its definition, although limited by the poor reproducibility of standard Hematoxylin & Eosin (H&E) evaluation. Phospho-histone-H3 (PHH3) and Ki-67 have been proposed as alternative assays of cellular proliferation. Therefore in the present series of 141 LGG, the molecular characterization (namely IDH status, 1p/19q co-deletion and MGMT promoter methylation) was integrated with the tumor "proliferative trait" (conventional H&E or PHH3-guided mitotic count and Ki-67 index) in term of prognosis definition. Exclusively high PHH3 and Ki-67 values were predictor of poor prognosis (log rank test, P = 0.0281 for PHH3 and P = 0.032 for Ki-67), unlike standard mitotic count. Based on Cox proportional hazard regression analyses, among all clinical (age), pathological (PHH3 and Ki-67) and molecular variables (IDH, 1p/19q codeletion and MGMT methylation) with a prognostic relevance at univariate survival analysis, only IDH expression (P = 0.001) and Ki-67 proliferation index (P = 0.027) proved to be independent prognostic factors. In addition, stratifying by IDH expression status, high Ki-67 retained its prognostic relevance uniquely in the IDH negative patient (P = 0.029) doubling their risk of death (hazard ratio = 2.27). Overall, PHH3 immunostaining is the sole reliable method with a prognostic value to highlight mitotic figures in LGG. Ki-67 proliferation index exceeds PHH3 mitotic count as a predictor of patient's prognosis, and should be integrated with molecular markers in a comprehensive grading system for LGG.

AB - Despite several molecular signatures for "lower grade diffuse gliomas" (LGG) have been identified, WHO grade still remains a cornerstone of treatment guidelines. Mitotic count bears a crucial role in its definition, although limited by the poor reproducibility of standard Hematoxylin & Eosin (H&E) evaluation. Phospho-histone-H3 (PHH3) and Ki-67 have been proposed as alternative assays of cellular proliferation. Therefore in the present series of 141 LGG, the molecular characterization (namely IDH status, 1p/19q co-deletion and MGMT promoter methylation) was integrated with the tumor "proliferative trait" (conventional H&E or PHH3-guided mitotic count and Ki-67 index) in term of prognosis definition. Exclusively high PHH3 and Ki-67 values were predictor of poor prognosis (log rank test, P = 0.0281 for PHH3 and P = 0.032 for Ki-67), unlike standard mitotic count. Based on Cox proportional hazard regression analyses, among all clinical (age), pathological (PHH3 and Ki-67) and molecular variables (IDH, 1p/19q codeletion and MGMT methylation) with a prognostic relevance at univariate survival analysis, only IDH expression (P = 0.001) and Ki-67 proliferation index (P = 0.027) proved to be independent prognostic factors. In addition, stratifying by IDH expression status, high Ki-67 retained its prognostic relevance uniquely in the IDH negative patient (P = 0.029) doubling their risk of death (hazard ratio = 2.27). Overall, PHH3 immunostaining is the sole reliable method with a prognostic value to highlight mitotic figures in LGG. Ki-67 proliferation index exceeds PHH3 mitotic count as a predictor of patient's prognosis, and should be integrated with molecular markers in a comprehensive grading system for LGG.

KW - Ki-67 index

KW - Lower grade gliomas

KW - Pathology Section

KW - Phospho-histone H3

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=84965047842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84965047842&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.8498

DO - 10.18632/oncotarget.8498

M3 - Article

AN - SCOPUS:84965047842

VL - 7

SP - 21190

EP - 21198

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 16

ER -